Click here for slides on this topic


Neuropathy

Damage to the nervous system resulting from chronic poorly controlled diabetes. Four different forms of neuropathy can be distinguished: peripheral sensorimotor neuropathy, autonomic neuropathy, mononeuritis simplex, and polyradiculopathy. Peripheral sensorimotor and autonomic neuropathies are much more common than mononeuritis simplex and polyradiculopathy. Peripheral neuropathy affects the motor and sensory nerves that control sensation and motor tone. Autonomic neuropathy affects the nerves involved in such involuntary functions as digestion.
The following content matched the glossary term: Neuropathy

AACE 2015 guidelines Microvascular Complications

Top

Recommendations for managing microvascular complications, including retinopathy, nephropathy, and neuropathy from the 2015 AACE diabetes guidelines 

ADA 2016 Microvascular Complications Foot Care

Top

Recommendations for preventing and managing microvascular complications of diabetes from the 2016 ADA diabetes guidelines

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 8, 2012

Top

Daily coverage of American Diabetes Association 72nd Scientific Sessions  June 8, 2012

Diabetes and hypoglycemia, clinical management of diabetes, obesity treatment, diabetes in long-term care, and more. 

Glycemic Control: How Low Should You Go?

Top

Glycemic Control: How Low Should You Go? NDEI Education Council Co-Chair Burton E. Sobel, MD, provides expert commentary on the debate over intensive versus somewhat less intensive glycemic control in the context of a recent study by Zhao et al assessing the impact of hypoglycemia associated with antihyperglycemic medications on vascular risk in type 2 diabetes

Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians

Top

Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P for the Clinical Guidelines Committee of the American College of Physicians. Oral pharmacologic treatment of type 2 diabetes mellitus a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156(3):218-231. The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the comparative effectiveness and safety of type 2 diabetes medications. METHODS This guideline is based on a systematic evidence review evaluating literature published

Differences in the diagnosis and management of type 2 diabetes in 3 countries (US, UK, and Germany): results from a factorial experiment

Top

von dem Knesebeck O, Gerstenberger E, Link C, et al. Differences in the diagnosis and management of type 2 diabetes in 3 countries (US, UK, and Germany): results from a factorial experiment. Med Care. 2010;48(4):321-326. This article examines the diagnosis and management of type-2 diabetes when exactly the same "patient" is encountered by 192 randomly selected primary care doctors in 3 different health care systems--the United States, United Kingdom, and Germany.

Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus

Top

Ai M, Otokozawa S, Schaefer EJ, et al. Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus. Clin Chimica Acta.. 2009;406(1-2):71-74. Diabetes mellitus is a major risk factor for coronary heart disease (CHD), renal failure, retinopathy, and neuropathy. Lowering glycosylated hemoglobin (HbA1c) as well as low-density lipoprotein-cholesterol (LDL-C) has been associated with a decreased risk of these complications.

Elevated triglycerides correlate with progression of diabetic neuropathy

Top

Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009;58(7):1634-1640. OBJECTIVE: To evaluate mechanisms underlying diabetic neuropathy progression using indexes of sural nerve morphometry obtained from two identical randomized, placebo-controlled clinical trials.

Recent advances in the management of type 2 diabetes mellitus: a review

Top

Srinivasan BT, Jarvis J, Hhunti K, Davies MJ. Recent advances in the management of type 2 diabetes mellitus: a review. Postgrad Med J. Postgrad Med J. 2008;84(996):524-531. Type 2 diabetes mellitus (T2DM) is a progressive disorder caused by a combination of insulin resistance and beta cell dysfunction. It is associated with an increased and premature risk of cardiovascular disease as well as specific microvascular complications such as retinopathy, nephropathy and neuropathy.

1 2 3 4 Next 

Slide Library Results

Search Results for: Neuropathy Slides Found: 26
Microvascular Complications in Hispanics and Non-Hispanic Whites
Rates of End-Stage Renal Disease in Diabetes Four Ethnic Groups
Nontraumatic Lower Extremity Amputation and Type 2 Diabetes
Incidence of Type 2 Diabetes-Related Vascular Disease in Four Ethnic Groups
Relationship Between Flow-Mediated Brachial Artery Dilation and Weight Loss After Lifestyle Modification
Changes in Flow-Mediated Brachial Artery Dilation After 6 Months of Lifestyle Modification
Meta-Analysis: A1C and CVD in Type 2 Diabetes
Steno-2: Effect of Multifactorial Intervention on Diabetic Neuropathies
VADT: Comparing Intensive With Standard Glucose Therapy, Primary Outcome
VADT: Comparing Intensive With Standard Glucose Therapy, Secondary Outcomes
VADT: Primary Endpoint
VADT: Effect of BMI on Rates of Severe Hypoglycemia
ACCORD: Factors Associated with Increased Hypoglycemia Risk in Intensive and Standard Treatment Arms
AHA/ACC/TOS Obesity Guidelines: Complications Seen With Bariatric Surgery
IDF Type 2 Diabetes Guidelines Foot Care | NDEI
IDF Type 2 Diabetes Guidelines Neuropathy | NDEI
IDF Type 2 Diabetes Guidelines In-Patient Critically Ill | NDEI
Statin Use and the Risk of Microvascular Disease | NDEI
ACCORD-MIND Hypoglycemia Age, Intensive Therapy, Diabetes Duration | NDEI
Pregnancy Recommendations ADA Type 1 Diabetes Guidelines | NDEI
AACE 2015 Diabetes Guidelines Neuropathy Management PPT | NDEI
Physical Activity Recommendations 2016 ADA Diabetes Guidelines | NDEI
Neuropathy Management ADA Diabetes Guidelines 2016 | NDEI PPT
Peripheral Neuropathy Diagnosis Foot Care Guidelines PPT | NDEI
Therapeutic Footwear to Prevent Diabetic Foot Ulcers Guidelines PPT | NDEI
Diabetic Foot Osteomyelitis Diabetic Foot Care Guidelines PPT | NDEI